— Know what they know.
Not Investment Advice

ISOLF OTC

Isodiol International Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +900.0% 3Y: -80.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $4914 mcap · 44M float · 0.0016% daily turnover

Income Trends

Revenue
$17M +12.2% ▲
3Y CAGR: +986.7%
Gross Profit
-$4M -113.4% ▼
Operating Income
-$29M -61.7% ▼
Net Income
-$90M -223.1% ▼
EPS (Diluted)
$-2.35 -76.7% ▼
EBITDA
-$84M -214.7% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2015FY2016FY2017FY2018
Revenue$13K$267K$15M$17M
YoY Growth+0.0%+1956.9%+5461.5%+12.2%
Cost of Revenue$5K$172K$17M$21M
Gross Profit$8K$95K-$2M-$4M
Gross Margin61.8%35.6%-12.8%-24.3%
R&D Expenses$0$103K$467K$81K
SG&A Expenses$2M$3M$16M$25M
Operating Expenses$2M$3M$16M$25M
Operating Income-$2M-$3M-$18M-$29M
Operating Margin-14751.9%-970.1%-121.8%-175.5%
Interest Expense$58K$72K$2K$4M
Income Before Tax-$7M-$3M-$28M-$91M
Tax Expense$0-$17K$227K-$225K
Net Income-$7M-$3M-$28M-$90M
Net Margin-51697.6%-1204.1%-188.2%-542.1%
EPS (Diluted)$-4.53$-1.01$-1.33$-2.35
EBITDA-$7M-$3M-$27M-$84M
Shares Outstanding1M3M21M38M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms